Search filters

List of works by Holger Hinrichsen

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.

scientific article published on April 2005

Chronic portal vein thrombosis: transcapsular hepatic collateral vessels and communicating ectopic varices

scientific article published on 09 September 2010

Cost of treating hepatitis C in Germany: a retrospective multicenter analysis

scientific article

Current recommendations for the treatment of chronic hepatitis C

scientific article

DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery

scientific article published on August 2013

Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial

scientific article published on 22 March 2013

Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation ⬇️

scientific article published on 01 May 2003

Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?

scientific article

Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections

scientific article published on 06 November 2019

Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial

scientific article published in August 2007

Erythema gyratum repens: drug reaction following azathioprine administration in a patient with type I autoimmune hepatitis

scientific article published in July 2002

Estimation of liver fibrosis by non-commercial serum markers in comparison to transient elastography in patients with chronic hepatitis C virus infection receiving direct acting antiviral treatment

article

Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection

scientific article published on 02 December 2019

Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies

scientific article

Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection

scientific article published on 23 June 2008

Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis

scientific article published on 20 February 2014

Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection

scientific article published on 2 November 2006

Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

article

Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms

scientific article published on 19 January 2019

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.

scientific article

Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register)

scientific article published on 01 November 2019

Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis

scientific article published on 01 August 2018

Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infection

scientific article published on 21 October 2011

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients

scientific article published in August 2009

Long-term follow-up after successful interferon therapy of acute hepatitis C.

scientific article published on July 2004

Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

scientific article published in December 2002

Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.

scientific article

Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals

scientific article published on 13 November 2017

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.

scientific article published on August 2005

Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment.

scientific article

Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection

scientific article published in November 2008

Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy

scientific article published on March 2013

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

scientific article published in March 2003

Prevalence of and risk factors for hepatitis G (HGV) infection in haemodialysis patients: a multicentre study

scientific article published in February 2002

Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease

scientific article published on 24 December 2016

Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C.

scientific article published on 13 January 2011

Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection

scientific article published on 21 April 2016

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

scientific article

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study

scientific article

Stent placement with the monorail technique for treatment of mesenteric artery stenosis

scientific article

Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity

scientific article published on 16 November 2015

The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection

scientific article published on 13 September 2011

Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis

scientific article

Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.

scientific article published on 4 March 2008

Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.

scientific article published on 24 June 2009

Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA

scientific article

Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance-associated substitutions

scientific article published on 08 July 2020

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial

scientific article published on June 2003

Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry

scientific article published on 25 April 2020

Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.

scientific article published in January 2006

[Erythema gyratum repens. Drug hypersensitivity after azathioprine in a patient with type 1 autoimmune hepatitis]

scientific article published on 01 December 2002

[In Process Citation]

[Main symptom jaundice--differential diagnosis at the bedside]

scientific article published on 01 January 2007

Paulina is supported by:

About Paulina

Help